Global Contract Pharmaceutical Dose Manufacturing Industry Report 2021 – ResearchAndMarkets.com

Global Contract Pharmaceutical Dose Manufacturing Industry Report 2021 – ResearchAndMarkets.com




Global Contract Pharmaceutical Dose Manufacturing Industry Report 2021 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Contract Pharmaceutical Dose Manufacturing Industry – Composition, Size, Market Share and Outlook, 2021 Edition” report has been added to ResearchAndMarkets.com’s offering.

This expert trend report is a comprehensive look at the finished dose contract manufacturing landscape in 2021, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

This expert trend report is a comprehensive look at the finished commercial dose contract manufacturing landscape in 2021, including analysis of dose CMO M&A activity, market size and share. It is a critical source for strategic planning efforts and will improve understanding of crucial components of the supply chain that will provide insights for supplier selection and management.

This report gives an important expert quantitative analysis on the commercial contract dose manufacturing industry. Findings are based on the industry’s most comprehensive database of the dose CMO industry (Contract Service Providers Database) this analysis is driven by a proprietary model of the dose manufacturing industry, which is continuously updated and refined. The 8 tables and 21 figures throughout the report illustrate major points and trends.

Scope

  • CMO executives and strategic decision-makers: improves understanding of the dose CMO industry and a critical input for strategic planning efforts.
  • Sourcing and procurement executives in bio/pharmaceutical companies: improving understanding of crucial components of the supply base that will provide insights for supplier selection and management.
  • Private equity investors: they can deeper understanding of the dose CMO market and important insight for identifying potential investment targets.

Reasons to Buy

  • What is the geographic reach of Commercial Dose CMOs?
  • What are the 2020 revenues generated by Commercial Contract dose manufacturing industry?
  • What are the components of revenue change for Contract Dose Manufacturers?
  • What is the breakdown of 2020 revenues by different dosage forms?
  • What are the characteristics of the largest dose CMOs?
  • How did the revenue growth of Contract Dose manufacturers in 2020 compare to Contract API manufacturers?
  • What is the outlook for the dose CMO industry?
  • What Dose CMO M&A deals occurred in 2020?

Key Topics Covered:

  • Executive Summary
  • Players
  • Trends
  • Industry Analysis
  • Industry Size and Structure
  • Industry Demographics
  • Major Developments Affecting Industry Structure
  • Industry Size and Growth
  • Dose Manufacturing
  • CMO Market Shares
  • Characteristics of the Largest CMOs
  • CMOs and Payment Protection Program Loans
  • Analyzing Recent Dose CMO Industry Performance
  • The COVID-19 Impact
  • Public CMO Sales Analysis
  • Changing Nature of Innovative FDA Approvals
  • What It Means
  • Value Chain
  • Companies

For more information about this report visit https://www.researchandmarkets.com/r/42yod3

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900